Published in Vaccine Weekly, March 23rd, 2011
"In CB6F1 mice we show that Rv2660c is stably expressed in late stages of infection despite an overall reduced transcription....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-03-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.